4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-23-001473
Chief Operating Officer gave up 2,450 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Devroe Eric · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-14 | Shares withheld for taxes : show line 1 in the form | −2,450 | $5.08 | $12,446 | 60,433 | D |
Loading xslF345X05/form4.xml…